Computational assessment of pigment epithelium-derived factor as an anti-cancer protein during its interaction with the receptors

References

• Assareh, E., Mehrnejad, F., & Asghari, S. M. (2020). Structural studies on an anti-angiogenic peptide using molecular modeling. Iranian Journal of Biotechnology, 18(4), e2553.
   PubMed Web of Science ®Google Scholar
• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Assareh, E., Mehrnejad, F., Mansouri, K., Esmaeili Rastaghi, A. R., Naderi-Manesh, H., & Asghari, S. M. (2019). A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth. The Biochemical Journal, 476(4), 645–663. https://doi.org/10.1042/BCJ20180823
   PubMedGoogle Scholar
• Azim, S., & Ahmad, Z. (2018). Glu residues of βDELSEED-motif are essential for peptide binding in Escherichia coli ATP synthase. International Journal of Biological Macromolecules, 116, 977–982. https://doi.org/10.1016/j.ijbiomac.2018.05.118
   PubMed Web of Science ®Google Scholar
• Balsera, B., Bonache, M., Reille-Seroussi, M., Gagey-Eilstein, N., Vidal, M., González-Muñiz, R., & Pérez de Vega, M. (2017). Disrupting VEGF–VEGFR1 interaction: De novo designed linear helical peptides to mimic the VEGF13-25 fragment. Molecules, 22(11), 1846. https://doi.org/10.3390/molecules22111846
   PubMed Web of Science ®Google Scholar
• Becerra, S. P., & Notario, V. (2013). The effects of PEDF on cancer biology: Mechanisms of action and therapeutic potential. Nature Reviews. Cancer, 13(4), 258–271. https://doi.org/10.1038/nrc3484
   PubMed Web of Science ®Google Scholar
• Behelgardi, M. F., Zahri, S., Mashayekhi, F., Mansouri, K., & Asghari, S. M. (2018). A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis. Scientific Reports, 8(1), 1–13. https://doi.org/10.1038/s41598-018-36394-0
   PubMedGoogle Scholar
• Belinsky, G. S., Sreekumar, B., Andrejecsk, J. W., Saltzman, W. M., Gong, J., Herzog, R. I., Lin, S., Horsley, V., Carpenter, T. O., & Chung, C. (2016). Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade . FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 30(8), 2837–2848. https://doi.org/10.1096/fj.201500027R
   PubMed Web of Science ®Google Scholar
• Berjanskii, M., Liang, Y., Zhou, J., Tang, P., Stothard, P., Zhou, Y., Cruz, J., MacDonell, C., Lin, G., Lu, P., & Wishart, D. S. (2010). PROSESS: A protein structure evaluation suite and server. Nucleic Acids Research, 38(Web Server issue), W633–W640. https://doi.org/10.1093/nar/gkq375
   PubMed Web of Science ®Google Scholar
• Bernard, A., Gao-Li, J., Franco, C.-A., Bouceba, T., Huet, A., & Li, Z. (2009). Laminin Receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor. The Journal of Biological Chemistry, 284(16), 10480–10490. https://doi.org/10.1074/jbc.M809259200
   PubMed Web of Science ®Google Scholar
• Bhojwani, H. R., & Joshi, U. J. (2017). Pharmacophore and docking guided virtual screening study for discovery of type I inhibitors of VEGFR-2 kinase. Current Computer-Aided Drug Design, 13(3), 186–207. https://doi.org/10.2174/1386207319666161214112536
   PubMed Web of Science ®Google Scholar
• Bhutto, I. A., McLeod, D. S., Hasegawa, T., Kim, S. Y., Merges, C., Tong, P., & Lutty, G. A. (2006). Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Experimental Eye Research, 82(1), 99–110. https://doi.org/10.1016/j.exer.2005.05.007
   PubMed Web of Science ®Google Scholar
• Bourhis, E., Wang, W., Tam, C., Hwang, J., Zhang, Y., Spittler, D., Huang, O. W., Gong, Y., Estevez, A., Zilberleyb, I., Rouge, L., Chiu, C., Wu, Y., Costa, M., Hannoush, R. N., Franke, Y., & Cochran, A. G. (2011). Wnt antagonists bind through a short peptide to the first β-propeller domain of LRP5/6. Structure (London, England: 1993), 19(10), 1433–1442. https://doi.org/10.1016/j.str.2011.07.005
   PubMed Web of Science ®Google Scholar
• Broadhead, M. L., Dass, C. R., & Choong, P. F. (2009). In vitro and in vivo biological activity of PEDF against a range of tumors. Expert Opinion on Therapeutic Targets, 13(12), 1429–1438. https://doi.org/10.1517/14728220903307475
   PubMed Web of Science ®Google Scholar
• Brozzo, M. S., Bjelić, S., Kisko, K., Schleier, T., Leppänen, V.-M., Alitalo, K., Winkler, F. K., & Ballmer-Hofer, K. (2012). Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization. Blood, 119(7), 1781–1788. https://doi.org/10.1182/blood-2011-11-390922
   PubMed Web of Science ®Google Scholar
• Champagne, E., Martinez, L. O., Collet, X., & Barbaras, R. (2006). Ecto-F1Fo ATP synthase/F1 ATPase: Metabolic and immunological functions. Current Opinion in Lipidology, 17(3), 279–284. https://doi.org/10.1097/01.mol.0000226120.27931.76
   PubMed Web of Science ®Google Scholar
• Chatterjee, S., & Bhattacharjee, B. (2012). Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor. Bioinformation, 8(25), 1249–1254. https://doi.org/10.6026/97320630081249
   PubMedGoogle Scholar
• Chelliah, S., Mock, C. D., Mathew, O. P., & Ranganna, K. (2018). Discovery of vascular endothelial growth factor receptor‐2 (VEGFR‐2) inhibitors by ligand‐based virtual high throughput screening. The FASEB Journal, 32(S1), 530.18–.18. https://doi.org/10.1096/fasebj.2018.32.1_supplement.530.18
   Google Scholar
• Chi, S. L., Wahl, M. L., Mowery, Y. M., Shan, S., Mukhopadhyay, S., Hilderbrand, S. C., Kenan, D. J., Lipes, B. D., Johnson, C. E., Marusich, M. F., Capaldi, R. A., Dewhirst, M. W., & Pizzo, S. V. (2007). Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase. Cancer Research, 67(10), 4716–4724. https://doi.org/10.1158/0008-5472.CAN-06-1094
   PubMed Web of Science ®Google Scholar
• Cioce, V., Castronovo, V., Shmookler, B. M., Garbisa, S., Grigioni, W. F., Liotta, L. A., & Sobel, M. E. (1991). Increased expression of the laminin receptor in human colon cancer. Journal of the National Cancer Institute, 83(1), 29–36. https://doi.org/10.1093/jnci/83.1.29
   PubMedGoogle Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science: A Publication of the Protein Society, 2(9), 1511–1519. https://doi.org/10.1002/pro.5560020916
   PubMed Web of Science ®Google Scholar
• Comeau, S. R., Gatchell, D. W., Vajda, S., & Camacho, C. J. (2004). ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics (Oxford, England), 20(1), 45–50. https://doi.org/10.1093/bioinformatics/btg371
   PubMed Web of Science ®Google Scholar
• DeLano, W. L. (2002). Pymol: An open-source molecular graphics tool. CCP4 Newsletter on Protein Crystallography, 40(1), 82–92.
   Google Scholar
• Deshpande, M., Notari, L., Subramanian, P., Notario, V., & Becerra, S. P. (2012). Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity. International Journal of Oncology, 41(1), 219–227.
   PubMed Web of Science ®Google Scholar
• Eisenberg, D., Lüthy, R., & Bowie, J. (1997). VERIFY3D: Assessment of protein models with three-dimensional profiles. In Methods in enzymology (Vol. 277, pp. 396–404). Academic Press. DOI.10:s0076–6879.
   Google Scholar
• Ek, E. T., Dass, C. R., & Choong, P. F. (2006). PEDF: A potential molecular therapeutic target with multiple anti-cancer activities. Trends in Molecular Medicine, 12(10), 497–502. https://doi.org/10.1016/j.molmed.2006.08.009
   PubMed Web of Science ®Google Scholar
• Enayatkhani, M., Salimi, M., Azadmanesh, K., & Teimoori-Toolabi, L. (2020). In-silico identification of new inhibitors for low-density lipoprotein receptor-related protein6 (LRP6). Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1857843
   Google Scholar
• Falk, T., Gonzalez, R. T., & Sherman, S. J. (2010). The Yin and Yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease. International Journal of Molecular Sciences, 11(8), 2875–2900. https://doi.org/10.3390/ijms11082875
   PubMed Web of Science ®Google Scholar
• Fan, W., Crawford, R., & Xiao, Y. (2011). The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization. Differentiation; Research in Biological Diversity, 81(3), 181–191. https://doi.org/10.1016/j.diff.2010.12.003
   PubMed Web of Science ®Google Scholar
• Feng, S., Zou, L., Ni, Q., Zhang, X., Li, Q., Zheng, L., Xie, L., Li, H., & Huang, D. (2014). Modulation, bioinformatic screening, and assessment of small molecular peptides targeting the vascular endothelial growth factor receptor. Cell Biochemistry and Biophysics, 70(3), 1913–1921. https://doi.org/10.1007/s12013-014-0151-x
   PubMed Web of Science ®Google Scholar
• Fujimura, Y., Sumida, M., Sugihara, K., Tsukamoto, S., Yamada, K., & Tachibana, H. (2012). Green tea polyphenol EGCG sensing motif on the 67-kDa laminin receptor. PloS One, 7(5), e37942. https://doi.org/10.1371/journal.pone.0037942
   PubMed Web of Science ®Google Scholar
• Gao, L., Chen, B., Li, J., Yang, F., Cen, X., Liao, Z., & Long, X. (2017). Wnt/β-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms. PloS One, 12(8), e0181346. https://doi.org/10.1371/journal.pone.0181346
   PubMed Web of Science ®Google Scholar
• García-Aranda, M. I., González-López, S., Santiveri, C. M., Gagey-Eilstein, N., Reille-Seroussi, M., Martín-Martínez, M., Inguimbert, N., Vidal, M., García-López, M. T., Jiménez, M. A., González-Muñiz, R., & Pérez de Vega, M. J. (2013). Helical peptides from VEGF and Vammin hotspots for modulating the VEGF-VEGFR interaction. Organic & Biomolecular Chemistry, 11(11), 1896–1905. https://doi.org/10.1039/c3ob27312a
   PubMed Web of Science ®Google Scholar
• Guan, M., Yam, H., Su, B., Chan, K., Pang, C., & Liu, W. (2003). Loss of pigment epithelium derived factor expression in glioma progression. Journal of Clinical Pathology, 56(4), 277–282. https://doi.org/10.1136/jcp.56.4.277
   PubMed Web of Science ®Google Scholar
• Harries, R. L., Owen, S., Ruge, F., Morgan, M., Li, J., Zhang, Z., Harding, K. G., Torkington, J., Jiang, W. G., & Cai, J. (2018). Impact of pigment epithelium-derived factor on colorectal cancer in vitro and in vivo. Oncotarget, 9(27), 19192–19202. https://doi.org/10.18632/oncotarget.24953
   PubMedGoogle Scholar
• Heo, L., Park, H., & Seok, C. (2013). GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Research, 41(Web Server issue), W384–W388. https://doi.org/10.1093/nar/gkt458
   PubMed Web of Science ®Google Scholar
• Huang, T.-C., Chang, H.-Y., Hsu, C.-H., Kuo, W.-H., Chang, K.-J., & Juan, H.-F. (2008). Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B. Journal of Proteome Research, 7(4), 1433–1444. https://doi.org/10.1021/pr700742h
   PubMed Web of Science ®Google Scholar
• Huang, W.-T., Chong, I.-W., Chen, H.-L., Li, C.-Y., Hsieh, C.-C., Kuo, H.-F., Chang, C.-Y., Chen, Y.-H., Liu, Y.-P., Lu, C.-Y., Liu, Y.-R., & Liu, P.-L. (2019). Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1. Cancer Letters, 442, 287–298. https://doi.org/10.1016/j.canlet.2018.10.031
   PubMed Web of Science ®Google Scholar
• Johnston, E. K., Francis, M. K., & Knepper, J. E. (2015). Recombinant pigment epithelium-derived factor PEDF binds vascular endothelial growth factor receptors 1 and 2. In Vitro Cellular & Developmental Biology. Animal, 51(7), 730–738. https://doi.org/10.1007/s11626-015-9884-0
   PubMed Web of Science ®Google Scholar
• Kawaguchi, T., Yamagishi, S.-I., & Sata, M. (2010). Structure-function relationships of PEDF. Current Molecular Medicine, 10(3), 302–311. https://doi.org/10.2174/156652410791065255
   PubMed Web of Science ®Google Scholar
• Kim, J., Han, W., Park, T., Kim, E. J., Bang, I., Lee, H. S., Jeong, Y., Roh, K., Kim, J., Kim, J.-S., Kang, C., Seok, C., Han, J.-K., & Choi, H.-J. (2020). Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains. Nature Communications, 11(1), 1–11. https://doi.org/10.1038/s41467-020-19155-4
   PubMedGoogle Scholar
• Konidala, K. K., Bommu, U. D., & Pabbaraju, N. (2018). In silico insights into the identification of potential novel angiogenic inhibitors against human vegfr-2: A new sar-based hierarchical clustering approach. Journal of Receptor and Signal Transduction Research, 38(4), 372–383. https://doi.org/10.1080/10799893.2018.1531891
   PubMed Web of Science ®Google Scholar
• Kortemme, T., Kim, D. E., & Baker, D. (2004). Computational alanine scanning of protein-protein interfaces. Science's STKE: Signal Transduction Knowledge Environment, 2004(219), pl2. https://doi.org/10.1126/stke.2192004pl2
   PubMedGoogle Scholar
• Kumari, R., Kumar, R., & Lynn, A, Consortium OSDD (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations . Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., Thompson, J. D., Gibson, T. J., & Higgins, D. G. (2007). Clustal W and Clustal X version 2.0. Bioinformatics (Oxford, England), 23(21), 2947–2948. https://doi.org/10.1093/bioinformatics/btm404
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand–protein interaction diagrams for drug discovery. ACS Publications.
   Google Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. https://doi.org/10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Latham, A. M., Kankanala, J., Fearnley, G. W., Gage, M. C., Kearney, M. T., Homer-Vanniasinkam, S., Wheatcroft, S. B., Fishwick, C. W. G., & Ponnambalam, S. (2014). In silico design and biological evaluation of a dual specificity kinase inhibitor targeting cell cycle progression and angiogenesis. PloS One, 9(11), e110997. https://doi.org/10.1371/journal.pone.0110997
   PubMed Web of Science ®Google Scholar
• Lee, A. C.-L., Harris, J. L., Khanna, K. K., & Hong, J.-H. (2019). A comprehensive review on current advances in peptide drug development and design. International Journal of Molecular Sciences, 20(10), 2383. https://doi.org/10.3390/ijms20102383
   PubMed Web of Science ®Google Scholar
• Lu, C.-L., Xu, J., Yao, H.-J., Luo, K.-L., Li, J.-M., Wu, T., & Wu, G.-Z. (2016). Inhibition of human 67-kDa laminin receptor sensitizes multidrug resistance colon cancer cell line SW480 for apoptosis induction. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, 37(1), 1319–1325. https://doi.org/10.1007/s13277-015-3873-5
   PubMedGoogle Scholar
• Mafakher, L., Rismani, E., Rahimi, H., Enayatkhani, M., Azadmanesh, K., & Teimoori-Toolabi, L. (2022). Computational design of antagonist peptides based on the structure of secreted frizzled-related protein-1 (SFRP1) aiming to inhibit Wnt signaling pathway. Journal of Biomolecular Structure and Dynamics, 40(5), 2169–2120. https://doi.org/10.1080/07391102.2020.1835718
   PubMed Web of Science ®Google Scholar
• Mäkitie, R., Niinimäki, R., Kakko, S., Honkanen, T., Kovanen, P., & Mäkitie, O. (2018). Defective WNT signaling associates with bone marrow fibrosis-a cross-sectional cohort study in a family with WNT1 osteoporosis . Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 29(2), 479–487. https://doi.org/10.1007/s00198-017-4309-4
   PubMed Web of Science ®Google Scholar
• Markovic-Mueller, S., Stuttfeld, E., Asthana, M., Weinert, T., Bliven, S., Goldie, K. N., Kisko, K., Capitani, G., & Ballmer-Hofer, K. (2017). Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A. Structure (London, England: 1993), 25(2), 341–352. https://doi.org/10.1016/j.str.2016.12.012
   PubMed Web of Science ®Google Scholar
• Mirochnik, Y., Aurora, A., Schulze-Hoepfner, F. T., Deabes, A., Shifrin, V., Beckmann, R., Polsky, C., & Volpert, O. V. (2009). Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 15(5), 1655–1663. https://doi.org/10.1158/1078-0432.CCR-08-2113
   PubMed Web of Science ®Google Scholar
• Niu, G., & Chen, X. (2010). Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Current Drug Targets, 11(8), 1000–1017. https://doi.org/10.2174/138945010791591395
   PubMed Web of Science ®Google Scholar
• Notari, L., Arakaki, N., Mueller, D., Meier, S., Amaral, J., & Becerra, S. P. (2010). Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase . The FEBS Journal, 277(9), 2192–2205. https://doi.org/10.1111/j.1742-4658.2010.07641.x
   PubMed Web of Science ®Google Scholar
• Orgaz, J. L., Ladhani, O., Hoek, K. S., Fernández-Barral, A., Mihic, D., Aguilera, O., Seftor, E. A., Bernad, A., Rodríguez-Peralto, J. L., Hendrix, M. J. C., Volpert, O. V., & Jiménez, B. (2009). Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma. Oncogene, 28(47), 4147–4161. https://doi.org/10.1038/onc.2009.284
   PubMed Web of Science ®Google Scholar
• Pan, J., Sun, L.-C., Tao, Y.-F., Zhou, Z., Du, X.-L., Peng, L., Feng, X., Wang, J., Li, Y.-P., Liu, L., Wu, S.-Y., Zhang, Y.-L., Hu, S.-Y., Zhao, W.-L., Zhu, X.-M., Lou, G.-L., & Ni, J. (2011). ATP synthase ecto-α-subunit: A novel therapeutic target for breast cancer. Journal of Translational Medicine, 9(1), 1–15. https://doi.org/10.1186/1479-5876-9-211
   Google Scholar
• Park, K., Lee, K., Zhang, B., Zhou, T., He, X., Gao, G., Murray, A. R., & Ma, J.-X. (2011). Identification of a novel inhibitor of the canonical Wnt pathway. Molecular and Cellular Biology, 31(14), 3038–3051. https://doi.org/10.1128/MCB.01211-10
   PubMed Web of Science ®Google Scholar
• Pesapane, A., Di Giovanni, C., Rossi, F. W., Alfano, D., Formisano, L., Ragno, P., Selleri, C., Montuori, N., & Lavecchia, A. (2015). Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion. Oncotarget, 6(20), 18116–18133. https://doi.org/10.18632/oncotarget.4016
   PubMedGoogle Scholar
• Poorebrahim, M., Sadeghi, S., Rahimi, H., Karimipoor, M., Azadmanesh, K., Mazlomi, M. A., & Teimoori-Toolabi, L. (2017). Rational design of DKK3 structure-based small peptides as antagonists of Wnt signaling pathway and in silico evaluation of their efficiency. PloS One, 12(2), e0172217. https://doi.org/10.1371/journal.pone.0172217
   PubMed Web of Science ®Google Scholar
• Protiva, P., Gong, J., Sreekumar, B., Torres, R., Zhang, X., Belinsky, G. S., Cornwell, M., Crawford, S. E., Iwakiri, Y., & Chung, C. (2015). Pigment epithelium-derived factor (PEDF) inhibits Wnt/β-catenin signaling in the liver. Cellular and Molecular Gastroenterology and Hepatology, 1(5), 535–549. e14. https://doi.org/10.1016/j.jcmgh.2015.06.006
   PubMedGoogle Scholar
• Qingyi, Z., Lin, Y., Junhong, W., Jian, S., Weizhou, H., Long, M., Zeyu, S., & Xiaojian, G. (2009). Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: A differential proteomics approach. Cancer Investigation, 27(7), 794–801. https://doi.org/10.1080/07357900802175617
   PubMed Web of Science ®Google Scholar
• Rismani, E., Rahimi, H., Arab, S. S., Azadmanesh, K., Karimipoor, M., & Teimoori-Toolabi, L. (2018). Computationally design of inhibitory peptides against Wnt signaling pathway: In silico insight on complex of DKK1 and LRP6. International Journal of Peptide Research and Therapeutics, 24(1), 49–60. https://doi.org/10.1007/s10989-017-9589-1
   Web of Science ®Google Scholar
• Sadremomtaz, A., Ali, A. M., Jouyandeh, F., Balalaie, S., Navari, R., Broussy, S., Mansouri, K., Groves, M. R., & Asghari, S. M. (2020). Molecular docking, synthesis and biological evaluation of vascular endothelial growth factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the vascular endothelial growth factor receptor 1 (VEGFR1D2) for anticancer application. Signal Transduction and Targeted Therapy, 5(1), 1–4. https://doi.org/10.1038/s41392-020-0177-z
   PubMed Web of Science ®Google Scholar
• Sarnataro, D., Pepe, A., Altamura, G., De Simone, I., Pesapane, A., Nitsch, L., Montuori, N., Lavecchia, A., & Zurzolo, C. (2016). The 37/67kDa laminin receptor (LR) inhibitor, NSC47924, affects 37/67kDa LR cell surface localization and interaction with the cellular prion protein. Scientific Reports, 6(1), 1–13. https://doi.org/10.1038/srep24457
   PubMedGoogle Scholar
• Scheiman, J., Tseng, J.-C., Zheng, Y., & Meruelo, D. (2010). Multiple functions of the 37/67-kd laminin receptor make it a suitable target for novel cancer gene therapy. Molecular Therapy : The Journal of the American Society of Gene Therapy, 18(1), 63–74. https://doi.org/10.1038/mt.2009.199
   PubMed Web of Science ®Google Scholar
• Selvam, C., Mock, C. D., Mathew, O. P., Ranganna, K., & Thilagavathi, R. (2020). Discovery of vascular endothelial growth factor receptor‐2 (VEGFR‐2) inhibitors by ligand‐based virtual high throughput screening. Molecular Informatics, 39(7), 1900150. https://doi.org/10.1002/minf.201900150
   PubMed Web of Science ®Google Scholar
• Shahbaaz, M., Cloete, R., Grobbelaar, M., Sampson, S., & Christoffels, A. (2019). Structure based identification of novel inhibitors against ATP synthase of Mycobacterium tuberculosis: A combined in silico and in vitro study. International Journal of Biological Macromolecules, 135, 582–590. https://doi.org/10.1016/j.ijbiomac.2019.05.108
   PubMed Web of Science ®Google Scholar
• Shahik, S. M., Salauddin, A., Hossain, M. S., Noyon, S. H., Moin, A. T., Mizan, S., & Raza, M. T. (2021). Screening of novel alkaloid inhibitors for vascular endothelial growth factor in cancer cells: an integrated computational approach. Genomics & Informatics, 19(1), e6. https://doi.org/10.5808/gi.20068
   PubMedGoogle Scholar
• Söding, J., Biegert, A., & Lupas, A. N. (2005). The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Research, 33(Web Server issue), W244–W248. https://doi.org/10.1093/nar/gki408
   PubMed Web of Science ®Google Scholar
• Solanki, S., Verma, D., Solanki, R., Pant, K., Pant, B., Tripathi, V., & Thapliyal, A. (2020). Computational screening of drug-like properties of tinospora cordifolia against tuberculosis. International Journal of Current Research and Review, 12(21), 38–42. https://doi.org/10.31782/IJCRR.2020.122131
   Google Scholar
• Thysiadis, S., Mpousis, S., Avramidis, N., Katsamakas, S., Balomenos, A., Remelli, R., Efthimiopoulos, S., & Sarli, V. (2016). Discovery of novel phenoxazinone derivatives as DKK1/LRP6 interaction inhibitors: Synthesis, biological evaluation and structure-activity relationships. Bioorganic & Medicinal Chemistry, 24(5), 1014–1022. https://doi.org/10.1016/j.bmc.2016.01.025
   PubMed Web of Science ®Google Scholar
• Tina, K., Bhadra, R., & Srinivasan, N. (2007). PIC: protein interactions calculator. Nucleic Acids Research, 35(Web Server issue), W473–W476. https://doi.org/10.1093/nar/gkm423
   PubMed Web of Science ®Google Scholar
• Tsuchiya, T., Nakahama, K.-I., Asakawa, Y., Maemura, T., Tanaka, M., Takeda, S., Morita, M., & Morita, I. (2009). The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 25(2), 104–109. https://doi.org/10.1080/09513590802549841
   PubMed Web of Science ®Google Scholar
• Uehara, H., Miyamoto, M., Kato, K., Ebihara, Y., Kaneko, H., Hashimoto, H., Murakami, Y., Hase, R., Takahashi, R., Mega, S., Shichinohe, T., Kawarada, Y., Itoh, T., Okushiba, S., Kondo, S., & Katoh, H. (2004). Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Research, 64(10), 3533–3537. https://doi.org/10.1158/0008-5472.CAN-03-3725
   PubMed Web of Science ®Google Scholar
• Umbaugh, C. S., Diaz-Quiñones, A., Neto, M. F., Shearer, J. J., & Figueiredo, M. L. (2018). A dock derived compound against laminin receptor (37 LR) exhibits anti-cancer properties in a prostate cancer cell line model. Oncotarget, 9(5), 5958–5978. https://doi.org/10.18632/oncotarget.23236
   PubMedGoogle Scholar
• van Zundert, G. C. P., Rodrigues, J. P. G. L. M., Trellet, M., Schmitz, C., Kastritis, P. L., Karaca, E., Melquiond, A. S. J., van Dijk, M., de Vries, S. J., & Bonvin, A. M. J. J. (2016). The HADDOCK2.2 web server: User-friendly integrative modeling of biomolecular complexes . Journal of Molecular Biology, 428(4), 720–725. https://doi.org/10.1016/j.jmb.2015.09.014
   PubMed Web of Science ®Google Scholar
• Vangone, A., & Bonvin, A. M. (2015). Contacts-based prediction of binding affinity in protein-protein complexes. eLife, 4, e07454. https://doi.org/10.7554/eLife.07454
   PubMed Web of Science ®Google Scholar
• Vásquez, A. F., Reyes Munoz, A., Duitama, J., & Gonzalez Barrios, A. (2021). Discovery of new potential CDK2/VEGFR2 type II inhibitors by fragmentation and virtual screening of natural products. Journal of Biomolecular Structure & Dynamics, 39(9), 3285–3299.
   PubMed Web of Science ®Google Scholar
• Wang, L., Bao, Q.-C., Xu, X.-L., Jiang, F., Gu, K., Jiang, Z.-Y., Zhang, X.-J., Guo, X.-K., You, Q.-D., & Sun, H.-P. (2015). Discovery and identification of Cdc37-derived peptides targeting the Hsp90–Cdc37 protein–protein interaction. RSC Advances, 5(116), 96138–96145. https://doi.org/10.1039/C5RA20408A
   Web of Science ®Google Scholar
• Wang, L., Coric, P., Broussy, S., Di Stasi, R., Zhou, L., D'Andrea, L. D., Ji, L., Vidal, M., Bouaziz, S., & Liu, W.-Q. (2019). Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain 2. European Journal of Medicinal Chemistry, 169, 65–75. https://doi.org/10.1016/j.ejmech.2019.02.069
   PubMed Web of Science ®Google Scholar
• Wang, L., Zhou, L., Reille-Seroussi, M., Gagey-Eilstein, N., Broussy, S., Zhang, T., Ji, L., Vidal, M., & Liu, W.-Q. (2017). Identification of peptidic antagonists of vascular endothelial growth factor receptor 1 by scanning the binding epitopes of its ligands. Journal of Medicinal Chemistry, 60(15), 6598–6606. https://doi.org/10.1021/acs.jmedchem.7b00283
   PubMed Web of Science ®Google Scholar
• Webb, B., & Sali, A. (2016). Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics, 54(1), 5.6.1–5.6.37. https://doi.org/10.1002/cpbi.3
   PubMedGoogle Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Web Server issue), W407–W410. https://doi.org/10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., Jain, S., Lewis, S. M., Arendall, W. B., Snoeyink, J., Adams, P. D., Lovell, S. C., Richardson, J. S., & Richardson, D. C. (2018). MolProbity: More and better reference data for improved all-atom structure validation . Protein Science: A Publication of the Protein Society, 27(1), 293–315. https://doi.org/10.1002/pro.3330
   PubMed Web of Science ®Google Scholar
• Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M., & Vangone, A. (2016). PRODIGY: A web server for predicting the binding affinity of protein-protein complexes. Bioinformatics (Oxford, England), 32(23), 3676–3678. https://doi.org/10.1093/bioinformatics/btw514
   PubMed Web of Science ®Google Scholar
• Zanella, S., Bocchinfuso, G., De Zotti, M., Arosio, D., Marino, F., Raniolo, S., Pignataro, L., Sacco, G., Palleschi, A., Siano, A. S., Piarulli, U., Belvisi, L., Formaggio, F., Gennari, C., & Stella, L. (2019). Rational design of antiangiogenic helical oligopeptides targeting the vascular endothelial growth factor receptors. Frontiers in Chemistry, 7, 170. https://doi.org/10.3389/fchem.2019.00170
   PubMed Web of Science ®Google Scholar
• Zhang, L., Chen, J., Ke, Y., Mansel, R. E., & Jiang, W. G. (2006). Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. International Journal of Molecular Medicine, 17(5), 937–944. https://doi.org/10.3892/ijmm.17.5.937
   PubMed Web of Science ®Google Scholar
• Zhang, S. X., Wang, J. J., Gao, G., Parke, K., & Ma, J-x. (2006). Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. Journal of Molecular Endocrinology, 37(1), 1–12. https://doi.org/10.1677/jme.1.02008
   PubMed Web of Science ®Google Scholar
• Zhang, X., Feng, S., Liu, J., Li, Q., Zheng, L., Xie, L., Li, H., & Huang, D. (2017). Novel small peptides derived from VEGF125-136: Potential drugs for radioactive diagnosis and therapy in A549 tumor-bearing nude mice. Scientific Reports, 7(1), 1–13. https://doi.org/10.1038/s41598-017-04513-y
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Yang, S., Jiao, Y., Liu, H., Yuan, H., Lu, S., Ran, T., Yao, S., Ke, Z., Xu, J., Xiong, X., Chen, Y., & Lu, T. (2013). An integrated virtual screening approach for VEGFR-2 inhibitors. Journal of Chemical Information and Modeling, 53(12), 3163–3177. https://doi.org/10.1021/ci400429g
   PubMed Web of Science ®Google Scholar
• Zhou, D., Cheng, S.-Q., Ji, H.-F., Wang, J.-S., Xu, H.-T., Zhang, G.-Q., & Pang, D. (2010). Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer. Journal of Cancer Research and Clinical Oncology, 136(11), 1719–1727. https://doi.org/10.1007/s00432-010-0830-y
   PubMed Web of Science ®Google Scholar